文献リスト

1) Nomura S, Ozaki Y, Ikeda Y. Function and role of microparticles in various clinical settings. Thromb Res. 2008; 123: 8-23

2) Burnier L, Fontana P, Kwak BR, et al. Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost. 2009; 101: 439-51

3) Nomura S, Shouzu A, Taomoto K, et al. Assessment of ELISA Kit for platelet-derived microparticles by joint research at many institutes in Japan. J Atheroscler Thromb. 2009; 16: 878-87

4) Tushuizen ME, Diamant M, Sturk A, et al. Cell-derived microparticles in the pathogenesis of cardiovascular disease; friend or foe ？ Arterioscler Thromb Vasc Biol. 2011; 31: 4-9

5) Berkmans RJ, Sturk A, van Tienen LM, et al. Cell-derived vesicles exposing coagulant factor in saliva. Blood. 2011; 117: 3172-80

6) Nomura S, Tandon NN, Nakamura T, et al. High-shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells. Atherosclerosis 2001; 158: 277-87

7) Ueba T, Haze T, Sugiyama M, et al. Level, distribution and correlates of platelet-derived microparticles in healthy individuals with special reference to the metabolic syndrome. Thromb Haemost. 2008; 100: 280-5

8) Ueba T, Nomura S, Inami N, et al. Plasma level of platelet-derived microparticles is associated with coronary heart disease risk score in healthy men. J Atheroscler Thromb. 2010; 17: 342-9

9) Ueba T, Nomura S, Inami N, et al. Correlation and association of plasma interleukin-6 and plasma platelet-derived microparticles, markers of activated platelets, in healthy individuals. Thromb Res. 2010; 125: e329-34

10) Namba M, Tanaka A, Shimada K, et al. Circulating platelet-derived microparticles are associated with atherothrombotic events: a marker for vulnerable blood. Arterioscler Thromb Vasc Biol. 2007; 27: 255-6

11) Messer L, Alsaleh G, Freyssinet JM, et al. Microparticle-induced release of B-lymphocyte regulators by rheumatoid synoviocytes. Arthritis Res Ther. 2009; 11: R40

12) Boilard E, Nigrovic PA, Larabee K, et al. Platelets amplify inflammation in arthritis via collagen- dependent microparticle production. Science. 2010; 327: 580-3

13) Faiile D, Combes V, Mitchell AJ, et al. Platelet microparticles: a new player in malaria parasite cytoadherence to human brain endothelium. FASEB J. 2009; 23: 3449-58

14) Van der Zee PM, Biró E, Ko Y, et al. P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction. Clin Chem. 2006; 52: 657-64

15) Macey MG, Wolf SI, Lawson C. Microparticle formation after exposure of blood to activated endothelium under flow. Cytometry A. 2010; 77: 761-8

16) Flaumenhaft R, Dilks JR, Richardson J, et al. Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles. Blood. 2009; 113: 1112-21

17) Rank A, Nieuwland R, Delker R, et al. Cellular origin of platelet-derived microparticles in vivo. Thromb Res. 2010; 126: e255-9

18) Valadi H, Ekström K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a nevel mechanism of genetic exchange between cells. Nat Cell Biol. 2007; 9: 654-9

19) Ratajczak J, Miekus K, Kucia M, et al. Embryonic stem-cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizintal transfer of mRNA and protein delivery. Leukemia. 2006; 20: 847-56

20) Deregibus MC, Cantaluppi V, Calogero R, et al. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood. 2007; 110: 2440-8

21) Benameur T, Tual-Chalot S, Andriantsitohaina R, et al. PPAR is essential for microparticle-induced differentiation of mouse bone marrow-derived endothelial progenitor cells and angiogenesis. PLoS One. 2010; 5: e12392

22) Couper KN, Barnes T, Hafalla JCR, et al. Parasite-derived plasma microparticles contribute significantly to malaria infection-induced inflammation through potent macrophage stimulation. PLoS Pathogens. 2010; 6: e1000744

23) Bertrand J, Mfonkeu P, Gouado I, et al. Elevated cell-specific microparticles are a biological marker for cerebral dysfunctions in human severe malaria. PLoS One. 2010; 5: e13415

24) Bebawy M, Combes V, Lee E, et al. Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells. Leukemia. 2009; 23: 1643-9

25) Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med. 2008; 359: 938-49

26) Huisse MG, Ajzenberg N, Feldman L, et al. Microparticle-linked tissue factor activity and increased thrombin activity play a potential role in fibrinolysis failure in ST-segment elevation myocardial infarction. Thromb Haemost. 2009; 101: 734-40

27) Leroyer AS, Isobe H, Leseche G, et al. Cellular origins and thrombogenic activity of micro-particles isolated from human atherosclerotic plaques. J Am Coll Cardiol. 2007; 49: 772-7

28) Ghosh A, Li W, Febbraio M, et al. Platelet CD36 mediates interactions with endothelial cell-derived microparticles and contributes to thrombosis in mice. J Clin Invest. 2010; 116: 4665-74

29) Jasuja R, Furie B, Furie BC. Endothelium-derived but not platelet-derived protein disulfide isomerase is required for thrombus formation in vivo. Blood. 2010; 118: 1934-43

30) Perez-Casal M, Downey C, Fukudome K, et al. Activated protein C induces the release of microparticle-associated endothelial protein C receptor. Blood. 2005; 105: 1515-22

31) Brodsky SV, Zhang F, Nasjletti A, et al. Endothelium-derived microparticles impair endothelial function in vitro. Am J Physiol Heart Circ Physiol. 2004; 286: H1910-5

32) Mostefay HA, Agouni A, Carusio N, et al. Phosphatidylinisitol 3-kinase and xanthine oxidase regulate nitric oxide and reactive oxygen species productions by apoptotic lymphocyte microparticles in endothelial cells. J Immunol. 2008; 180: 5028-35

33) Amabili N, Guèrin AP, Leroyer A, et al. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol. 2005; 16: 3381-8

34) Abid-Hussein MN, Nieuwland R, Hau CM, et al. Cell-derived microparticles contain caspase 3 in vitro and in vivo. J Thromb Haemost. 2005; 3: 888-96

35) Abid-Hussein MN, Böing AN, Sturk A, et al. Inhibition of microparticle release triggers endothelial cell apoptosis and detachment. Thromb Haemost. 2007; 98: 1096-107

36) Diamant M, Tushuizen ME, Abid-Hussein MN, et al. Simvastatin-induced endothelial cell detachment and microparticle release are prenylation dependent. Thromb Haemost. 2008; 100: 489-97

37) Philippova M, Suter Y, Toggweiler S, et al. T-cadherin is present on endothelial micro-particles and is elevated in plasma in early atherosclerosis. Eur Heart J. 2011; 32: 760-71

38) Perez-Casal M, Downey C, Cutillas-Moreno B, et al. Microparticle- associated endothelial protein C receptor and the induction of cytoprotective and anti-inflammatory effects. Haematologica. 2009; 94: 387- 94

39) Mostefay HA, Meziani F, Mastronardi MI, et al. Circulating microparticles from patients with septic shock exert protective role in vascular function. Am J Respir Crit Care Med. 2008; 178: 1148-55

40) Leroyer AS, Rautou PE, Silverstre JS, et al. CD40 ligand ＋ microparticles from human athero-sclerotic plaques stimulate endothelial prolifera-tion and angiogenesis: a potential mechanism for intraplaque neovascularisation. J Am Coll Cardiol. 2008; 52: 1302-11

41) Pirro M, Schillaci G, Bagaglia F, et al. Micro-particles derived from endothelial progenitor cells in patients at different cardiovascular risk. Atherosclerosis. 2008; 197: 757-67

42) Huang PH, Huang SS, Chen YH, et al. Increased circulating CD31＋/annexin V- apoptotic microparticles and decreased circulating endothelial progenitor cells levels in hypertensive patients with microalbuminuria. J Hypertens. 2010; 28: 1655-65

43) Jayachandran M, Litwiller RD, Owen WG, et al. Characterization of blood borne microparticles as markers of premature coronary calcification in newly menopausal women. Am J Physiol Heart Circ Physiol. 2008; 295: H931-8

44) Chironi GN, Simon A, Boulanger CM, et al. Circulating microparticles may influence early carotid artery remodeling. J Hypertens. 2010; 28: 789-96

45) Nozaki T, Sugiyama S, Koga H, et al. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease. J Am Coll Cardiol. 2009; 54: 601-8

46) Van Eijk IC, Tushuizen ME, Sturk A, et al. Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis. Ann Rheum Dis. 2010; 69: 1378-82

47) Van der Zee PM, Biro E, Trouw LA, et al. C-reactive protein in myocardial infarction binds to circulating microparticles but is not associated with complement activation. Clincal Immunol. 2010; 135: 490-5

48) Po-Hsun H, Shao-Sung H, Yung-Hsiang C, et al. Increased circulating CD31＋/annexin V＋ apoptotic microparticles and decreased circulating endothelial progenitor cell levels in hypertensive patients with microalbuminuria. Hypertension. 2010; 28: 1655-65

49) Lackner P, Dietmann A, Beer R, et al. Cellular microparticles as a marker for cerebral vasospasm in spontaneous subarachnoid hemorrhage. Stroke. 2010; 41: 2353-7

50) Rodriguez PG, Eikenboom HC, Tesselaar ME, et al. Plasma levels of microparticle-associated tissue factor activity in patients with clinically suspected pulmonary embolism. Thromb Res. 2010; 126: 345-9

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp